SCHEMBL1225317

SCHEMBL1225317

COc1cccc(C=CC(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.49
LMNA P02545 1/20 0.49
TGFBR1 P36897 2/20 0.46
THRB P10828 1/20 0.45
ATM Q13315 1/20 0.45
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HSD17B10 Q99714 2/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41
IDH1 O75874 1/20 0.41
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC8 Q9BY41 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1225315 1.00 KDM4E (0.49) KDM4ELMNATGFBR1THRBATM
SCHEMBL4584461 0.87 KDM4E (0.51) KDM4ELMNATGFBR1ATMSMN1; SMN2
SCHEMBL4584462 0.87 KDM4E (0.51) KDM4ELMNATGFBR1ATMSMN1; SMN2
SCHEMBL3929433 0.85 TGFBR1 (0.45) KDM4ELMNATGFBR1ALDH1A1HPGD
SCHEMBL3929435 0.85 TGFBR1 (0.45) KDM4ELMNATGFBR1ALDH1A1HPGD
SCHEMBL12501357 0.83 TGFBR1 (0.44) KDM4ELMNATGFBR1SMN1; SMN2IDH1
SCHEMBL17318492 0.78 ABCG2 (0.61) KDM4EALDH1A1HPGDPOLB
SCHEMBL3614976 0.77 KDM4E (0.53) KDM4ELMNAALDH1A1HPGDHDAC3
SCHEMBL3614973 0.77 KDM4E (0.53) KDM4ELMNAALDH1A1HPGDHDAC3
SCHEMBL5756780 0.77 KDM4E (0.58) KDM4ELMNATGFBR1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110033393-A1 Hydrazone Compounds and Their Use REDPOINT BIO CORPORATION 2011-02-10 US disclosed
WO-2010132615-A1 HYDRAZONE COMPOUNDS AND THEIR USE STEIN PHILIP (US) 2010-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110033393-A1 Hydrazone Compounds and Their Use TRPM5, TRPV5, TRPM8 KDM4E 2023/4885LMNA 2883/4885TGFBR1 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.